Why the study?
Patients with cardiovascular disease are especially susceptible to drug-drug interactions due to factors such as multimorbidity, polypharmacy, and altered drug metabolism.
Population
Cardiac patients in tertiary care hospitals
Authors
Loading...
Warrants heightened pDDI vigilance during CVD prescribing; leaves open the outcomes of targeted mitigation strategies.
Potential drug-drug interactions are highly prevalent among cardiac inpatients, particularly involving common medications like aspirin and clopidogrel, highlighting the need for systematic surveillance.
Sultana et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: